Belarus-China company to launch heparin production in Brest Oblast
The production of raw heparin sodium and fodder protein is to be launched in Brest Oblast in the coming two years, BelTA learned from the Brestmyasomolprom Concern holding company. Such a production will be new to Belarus. It will be run by a Belarus-China joint venture.
The investment agreement was signed by Brestmyasomolprom Concern and a Chinese company that produces heparin. “Heparin is an anticoagulant; it prevents the clotting of blood.
It is used to treat patients with thrombosis, COVID-19, cancer, in cardiovascular surgeries and cosmetology. One kilogram of this product costs $16,000.
The main manufacturer is China. Pharmaceutical-grade heparin is derived from mucosal tissues of porcine (pig) intestines that are mostly disposed of
. Читать на udf.by